drugset / Trial / NCT06821945

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

NCT06821945 ↗

Phase 2 Recruiting 120 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia

Timeline

Start
2025-05-30
Primary completion
2027-05
Completion
2027-05

Drugs

EvaluationDrugModalityDoseRoute
Subject BR5402A Unknown — —
Subject BR5402B Unknown — —
Subject BR5402C Unknown — —
Subject BR5402D Unknown — —

Indications